
Company valuation, historical trends, and peer comparisons.
According to Hemostemix Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 14.00M. This represents a change of -15.42% compared to the average of 16.55M of the last 4 quarters.
The mean historical Enterprise Value of Hemostemix Inc. over the last ten years is 14.09M. The current 14.00M Enterprise Value has changed -0.62% with respect to the historical average. Over the past ten years (40 quarters), HMTXF's Enterprise Value was at its highest in in the December 2020 quarter at 27.52M. The Enterprise Value was at its lowest in in the March 2020 quarter at 3.57M.
Average
14.09M
Median
15.24M
Minimum
5.05M
Maximum
22.49M
Discovering the peaks and valleys of Hemostemix Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 345.33%
Maximum Annual Enterprise Value = 22.49M
Minimum Annual Increase = -77.48%
Minimum Annual Enterprise Value = 5.05M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 17.63M | 12.74% |
| 2024 | 15.64M | 57.31% |
| 2023 | 9.94M | -40.07% |
| 2022 | 16.59M | 58.66% |
| 2021 | 10.45M | -53.51% |
| 2020 | 22.49M | 345.33% |
| 2019 | 5.05M | -77.48% |
| 2018 | 22.42M | 285.98% |
| 2017 | 5.81M | -60.85% |
| 2016 | 14.84M | -61.19% |
The current Enterprise Value of Hemostemix Inc. (HMTXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
14.40M
5-year avg
14.05M
10-year avg
14.09M
Hemostemix Inc.’s Enterprise Value is greater than Nymox Pharmaceutical Corporation (2.09M), less than Devonian Health Group, Inc. (0), greater than HOOKIPA Pharma Inc. (-22891217.00), less than Algorae Pharmaceuticals Limited (17.09M), greater than EOM Pharmaceuticals Holdings, Inc. (10.91M), greater than Sirona Biochem Corp. (3.90M), greater than Oxford BioDynamics Plc (3.95M), greater than Inhibitor Therapeutics, Inc. (10.15M), greater than Quest PharmaTech Inc. (8.01M), less than Cell Source, Inc. (48.48M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 2.09M | $2.10M | |
| 0 | $16.34M | |
| -22891217.00 | $14.40M | |
| 17.09M | $7.10M | |
| 10.91M | $9.18M | |
| 3.90M | $1.63M | |
| 3.95M | $2.98M | |
| 10.15M | $10.62M | |
| 8.01M | $5.07M | |
| 48.48M | $35.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemostemix Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hemostemix Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Hemostemix Inc.'s Enterprise Value?
What is the highest Enterprise Value for Hemostemix Inc. (HMTXF)?
What is the 3-year average Enterprise Value for Hemostemix Inc. (HMTXF)?
What is the 5-year average Enterprise Value for Hemostemix Inc. (HMTXF)?
How does the current Enterprise Value for Hemostemix Inc. (HMTXF) compare to its historical average?